Inhibrx Biosciences Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$109.35

+4.62 (+4.41%)

As of Sep 20, 10:14 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 80%

Hold 2 20%

Sell 0 0%

Price Target

Analyst Price Target -83.4% upside

Low Target $12.39

Average Target $18.13

High Target $27.56

Current Price $109.35

Current
$109.35

Target
$18.13

$12.39 $18.13 avg $27.56

Scenario Analysis

Bear Case

$12.39

-88.7%

Low target

Base Case

$18.13

-83.4%

Avg target

Bull Case

$27.56

+-74.8%

High target

Risk/Reward

0.8x

Unfavorable

Price in Context

52-Week High

$155.29

-29.6% from high

52-Week Low

$26.19

+317.5% from low

Target vs 52W High

$18.13

-88.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-15.1%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-17.9%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.2%